LifeNet Health LifeSciences

This Thanksgiving, we want to express our heartfelt gratitude to our incredible team, partners, and the entire research community. Your dedication and collaboration have been instrumental in advancing scientific research and improving lives. We’d also like to give our sincerest appreciation to the donors and donor families. Without you, none of the amazing work we do would be possible. Thank you for being a part of our journey and for your unwavering commitment to scientific excellence. Wishing you all a warm and joyous Thanksgiving! #LifeSciences #Thanksgiving #Gratitude #ScientificResearch #LifeSciences #ThankYou

LifeNet Health LifeSciences has over 40 years of experience in ethical recovery. Our specialized recovery team excels in tissue identification and recovery, offering a broad range of tissue recovery options, including both healthy and diseased tissues. We also provide paired samples for recovery, and donor medical records can be redacted and sent after recovery, ensuring maximum donor data to support research. Discover how we’re advancing research with our expertise in recovery and specific protocols. https://lnkd.in/gW8VzCxi

LifeNet Health LifeSciences is making a significant impact on scientific research with its human biospecimens. With over 600 brains recovered, our commitment to advancing the study of brain health is stronger than ever. We have collaborated with 15 research organizations including: · Over 120 brains for the National Center for PTSD Brain Bank (Durham VAMC) and DUKE Neuropsychiatric Brain Bank · Over 120 brains for the Van Andel MiND Program Brain Bank Over 90 brains for Uniform Services University Brain Tissue Repository. To explore more of our case studies and to see how we’re making an impact in the biospecimens field, please visit the link below: https://lnkd.in/eStUenMr #LifeNetHealth #BrainRecovery #ScientificResearch #Biospecimens #LifeSciences #ResearchImpact

Are you having trouble sourcing a diverse range of mid-term and long-term plateable primary human hepatocytes (PHH) for your research? LifeNet Health has a portfolio of 147 donors, with 106 providing mid-term (5-10 days) and long-term (10-14 days) plateable PHH. Key highlights of LifeNet Health’s MT/LT plateable PHH offerings include: Health Status – 52 Healthy {NAS 0}, 10 Diseased {NAS 24} Quantity of Vials – 9 Lots with 900+ vials Race – 3 Asian, 13 Black, 16 Hispanic, 71 Caucasian Gender – 39 Female, 67 Male Life Stage – 96 Adult, 10 Pediatric/Juvenile LifeNet Health is committed to combining quantity, quality, and diversity to meet your research needs. Our extensive PHH portfolio offers a wide selection of high-quality cells, enhancing the relevance and translational potential of your studies. For more information on how we can help with your research needs, please visit the link below: https://lnkd.in/e6Bvmq8s #lifesciences #liverresearch

Are you struggling to find high-quality primary human hepatocytes (PHH) for your research? LifeNet Health has a diverse range of hepatocytes suitable for various research needs. Our extensive inventory not only offers a large quantity but also exceptional cell quality, with 10 lots containing over 900 vials each. Here's the breakdown of these valuable lots by cell longevity categories: · Long Term Plateable: 25 lots, including 3 lots with over 900 vials · Mid Term Plateable: 81 lots, including 6 lots with over 900 vials · Short Term Plateable: 11 lots, including 1 lot with over 900 vials · Suspension: 15 lots LifeNet Health's comprehensive PHH portfolio ensures a wide selection of high-quality PHH, enhancing the relevance and translational capacity of your research. For more information on how we can help with your research needs, please visit the link below: https://lnkd.in/e6Bvmq8s #lifesciences #liverresearch

Looking forward to attending this exclusive event at Le Meridien Boston Cambridge tomorrow! There, we'll be connecting with attendees and providing ways to support their research needs.

Facing issues with sourcing high-quality human cells and tissues for your research? Look no further. LifeNet Health LifeSciences boasts the largest liver portfolio, featuring primary human hepatocytes (PHH), non-parenchymal cells (NPCs), and liver tissues, capable of meeting all your research needs. With 147 Donors and over 40,000 vials, LifeNet Health LifeSciences offers: 10 lots with over 900 PHH vials Over 45 lots for NPCs Over 250 lots for SFT/FFPE tissues Our extensive PHH portfolio increases the likelihood of offering lots that meet your specific research needs, supporting the relevance and translational potential of your studies. For more information on how we can help with your research needs, please visit the link below: LifeNet Health LifeSciences | Hepatocytes #lifesciences #liverresearch

Breakthroughs in drug discovery often hinge on the quality and relevance of your research models. At LifeNet Health, we understand the liver’s central role in drug metabolism and toxicity and your need for highly reliable, diverse liver cells to propel your research forward. That’s why we offer the industry’s most extensive inventory of liver cells, including: · Well-characterized primary human hepatocytes · Kupffer, stellate, and liver endothelial cells from healthy and diseased tissues · Donor-matched snap-frozen and formalin-fixed tissue sample Connect with an expert today to learn more about how you can get the most accurate and reliable results with our diverse, high-quality cells and tissues. Or meet us in person at the 8th Annual MASH Drug Development Summit in Boston, MA. https://lnkd.in/eWkJ4kPF

TruVivo is here to revolutionize the way you characterize human mechanisms for the metabolism of drug candidates. We invite you to watch our on-demand webinar featuring Diane Ramsden, PhD, expert scientist in DMPK and toxicology, as she presents data from her evaluation of TruVivo as a potential tool for investigating mechanistic DMPK, including drug-drug interaction potential, and translational risk assessment. Don't miss out on this opportunity to unlock the potential of TruVivo. Click the link below! https://lnkd.in/eHiqFcq6

Meet us at the 8th Annual MASH Drug Development Summit to discover our primary human cells and access to human biospecimens. LifeNet Health LifeSciences’ meticulously curated liver cells offer: ? Diverse disease states: Covering a broad spectrum of fibrosis and MAFLD activity scores. ?Representative population: Featuring hepatocytes from donors of varying ages, ethnicities, and social histories. ?Comprehensive in vitro solution: Includes donor-matched cells, FFPE blocks, and snap-frozen tissues. ?Platform compatibility: Seamless integration with suspension, 2D, 3D, MPS, and TruVivo? platforms, saving you time and resources. Click the link below to learn more. https://lnkd.in/etaRQ5iF